期刊文献+

Apathy in Parkinson disease

Apathy in Parkinson disease
原文传递
导出
摘要 冷淡是 Parkinson 疾病(PD ) 的最少的调查症状之一。在文章,有在 PD 的冷淡的频率,诊断特征, pathophysiology 和处理的数据。调查的目的在 PD 评估冷淡的频率没有痴呆,与另外的 neuropsychiatric 评估关系并且交通混乱,对生活质量的影响。115 个病人(年龄 63. Apathy is one of the least investigated symptom of Parkinson disease (PD). In the article there are data of frequency, diagnostic features, pathophysiology and treatment of apathy in PD. The aim of the investigation was to evaluate the frequency of apathy in PD without dementia, evaluate the relationship with other neuropsychiatric and motor disorders, influence on the life quality. 115 patients (age-63.84±0.6 years, stage 2.6±0.3) with PD without dementia were included in the investigation. There were used the following scales: scale of evaluation stages of PD by Hoehn-Yahr, UPDRS (part 〈〈activity of daily living〉〉, 〈〈motor functions 〉〉); Beck Depression Inventory, Spielberger State Trait Anxiety Inventory, Parkinson Disease Sleep Scale- PDSS, Epworth Sleepiness Scale, Parkinson Fatigue Scale-PFS- 16, SCOPA-Cog, Lilli Apathy Rating Scale LARS and Apathy Scale AS. Apathy was found in 25% of patients. The frequency and severity of apathy does not depend on stage and duration of PD. It was found positive correlation of apathy and hypokinesia. In different stages of PD there was variability of relationships of apathy with depression, executive functions and sleep disorders. We suppose the heterogeneity of apathy in PD because of the variability of the association with other neuropsychiatric (affective, cognitive, sleep) disorders. It was found the negative influence of apathy on daily activity, emotional and social aspects of life quality.
出处 《Frontiers in Biology》 CAS CSCD 2014年第4期324-331,共8页 生物学前沿(英文版)
关键词 帕金森病 睡眠障碍 生活质量 运动功能 病理生理学 斯皮尔伯格 正相关关系 诊断功能 Parkinson disease, neuropsychiatric symptoms, apathy, heterogeneity
  • 相关文献

参考文献61

  • 1Aarsland D, Larsen J P, Lim N G, Janvin C, Karlsen K, Tandberg E, Cummings J L (1999). Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry, 67(4): 492–496.
  • 2Aarsland D, Mosimann U P, McKeith I G (2000). Role of cholinesterase inhibitors in Parkinsons disease and dementia with Lewy bodies. J Geriatr Psychiatry, 15(5): 387–392.
  • 3Alexander G E, Crutcher M D, DeLong M R (1990). Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res, 85: 119–146.
  • 4Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello T P, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio R M, Giglia R M, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri F E, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio A R, Stocchi F, Trianni G, Dotto P D, the PRIAMO study group (2009). The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord, 24(11): 1641–1649.
  • 5Beck A T, Streer R A, Brown K G, (1996). Manual for the Beck Depression Inventory —II. San Antonio, TX: Psychological Corporation.
  • 6Benito-León J, Cubo E, Coronell C, the ANIMO Study Group (2012). Impact of apathy on health-related quality of life in recently diagnosed Parkinson’s disease: the ANIMO study. Mov Disord, 27(2): 211–218.
  • 7Bogart K R (2011). Is apathy a valid and meaningful symptom or syndrome in Parkinson’s disease? A critical review. Health Psychol, 30(4): 386–400.
  • 8Bonelli R M, Cummings J L (2007). Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci, 9(2): 141–151.
  • 9Aarsland D, Br?nnick K, Alves G, Tysnes O B, Pedersen K F, Ehrt U, Larsen J P (2009). The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry, 80(8): 928–930.
  • 10Brown R G, Dittner A, Findley L, Wessely S C (2005). The Parkinson fatigue scale. Parkinsonism Relat Disord, 11(1): 49–55.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部